Global Flexible Packaging Market is Expected to Reach USD 99.10 Billion in 2019: Transparency Market Research

Chemical and MaterialsAccording to a new report published by Transparency Market Research “Flexible Packaging (Plastic, Paper, Aluminum Foil and Others) Market for Food & Beverages, Retail Non-Food, Pharmaceutical and Other Applications – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” the global demand for flexible packaging was valued at USD 73.56 billion in 2012 and is expected to reach USD 99.10 billion in 2019, growing at a CAGR of 4.4% from 2013 to 2019. In terms of volume, the demand was 18,666.0 kilo tons in 2012 and is expected to be 24,728.7 kilo tons in 2019, growing at a CAGR of 4.1% from 2013 to 2019.

Browse Global Flexible Packaging Market Report with Full TOC: http://www.transparencymarketresearch.com/flexible-packaging-industry.html

Increasing demand for flexible packaging in the healthcare industry is expected to be one of the key factors driving growth of the flexible packaging market. In addition, expansion of the food & beverages market, which is the largest application of flexible packaging, is expected to fuel the growth of the market. Furthermore, rising consumer preference towards light weight, durable and highly aesthetic flexible packaging is expected to significantly fuel the growth of the market over the next few years. However, volatility in the prices of crude oil which consequently affects the prices of its downstream chemicals is expected to hamper the packaging market adversely. Focused research and development activities on flexible packaging technologies have opened opportunities for the usage of nanotechnology in the formation of films and printing.

Plastics have been extensively used in flexible packaging due to their high barrier properties, cost effectiveness and durability and accounted for over 70% of the market share in 2012. However, growing consumer demand for biodegradable packaging material due to rising awareness regarding ecology conservation is expected is boost the demand for cellulose over the next six years. In addition, cellulose has been popular than other packaging materials due to its high durability, protection from external environmental factors such as sunlight and high aesthetic value. These factors are expected to contribute significantly to the growing demand for cellulose.

Demand for flexible packaging was highest from the food & beverages sector. Several regulations are being introduced and implemented across the world regarding packaging of pharmaceuticals due to various factors such as maintenance of hygiene, reduction of fraudulent drugs in the retail market and to retain the medicinal properties of the drug. Thus, flexible packaging is expected to witness the fastest growth in pharmaceutical within the forecast period and is expected to be valued at USD 11.09 billion in 2019.

Browse full PDF with TOC: Flexible Packaging Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Asia Pacific accounted for the highest demand in 2012, and is expected to be fastest growing region, rising at a CAGR of 4.4% from 2013 to 2019. This trend is expected to continue over the forecast period on account of rapid economic development in this region resulting in the growth of various industries such as food & beverages, personal care products and pharmaceuticals among others. Regions present in rest of the world are expected to witness a significant increase in consumption of packaging owing to economic development in countries such as Brazil.

The report gives a comprehensive view of the flexible packaging market in terms of volume and revenue. In addition, the report includes current demand analysis and forecast for each product and application in North America, Europe, Asia Pacific and Rest of the World. The report comprises of the following segments:

Flexible Packaging Market: Product Segment Analysis

  • Plastics
  • Paper
  • Aluminum foil
  • Cellulose

Flexible Packaging Market: Application Analysis

  • Food & Beverage
  • Retail non-food
  • Pharmaceutical
  • Others

Flexible Packaging Market: Regional Analysis

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Advertisements

Pulmonary Drug Delivery Systems Market Expected to Reach USD 28.7 Billion Globally in 2019: Transparency Market Research

Medical_Devices copyAccording to a new market report published by Transparency Market Research “Pulmonary Drug Delivery Systems Market(Products- Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications- Asthma, COPD and Cystic Fibrosis) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” the global pulmonary drug delivery systems market was valued at USD 21.03billion in 2012 and is expected to grow at a CAGR of4.5% from 2013 to 2019, to reach an estimated value of USD 28.70billion in 2019.

Browse Global Pulmonary Drug Delivery Systems Market Report with Full TOC: http://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html

Pulmonary drug delivery systems use the respiratory tract to deliver medications to treat diseases such as asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The history of use of these systems dates back to over 60 years ago, when these systems were initially indicated for treating only respiratory diseases – asthma and COPD. Continued development in this area facilitated their application in the treatment of other diseases as well, including cystic fibrosis and diabetes. Exubera was the first inhalable insulin launched by Pfizer Ltd. and Nektar Pharma for treating diabetes, in 2006. However,owing to its poor sales performance, Exubera was withdrawn from the market within a yearof its launch which led other partnerships such as Alkermes/Eli Lilly and Aradigm/Novo Nordisk to abandon the development process of inhalable insulin therapies. Currently,Afrezza by MannKind Corporation is the only inhalable insulin under review by the U.S. FDA and is likely to be approved for marketing in the U.S. by mid-2014.

The global market for pulmonary drug delivery systems includes metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers. Initially, MDIs used chlorofluorocarbons (CFCs) as propellants.Later due to rising environmental concerns and pressure from Montreal Protocol (1987) recommendation to phase out CFCs, manufacturers started using hydrofluoroalkanes (HFAs) that are considered as safe propellants causing negligible threat ofozone depletion.MDIs accounted for the largest share (56.8%) of the total global pulmonary drug delivery systems market in 2012 and this segment is expected to grow at a CAGR relatively lower than that for DPIs and nebulizer market segments. This is primarily because of the environmental concerns related with the use of CFCs, which led to ban on CFC-based inhalers. Although manufacturers have now started using HFAs the fact that HFAs also emit gases causing ozone layer depletion has led manufacturers to shift their focus more towards the development of DPIs. During the forecast period 2013 to 2019, DPIs are expected to witness greater demand than MDIs owing to propellant free nature of these systems. The market for nebulizers has been anticipated as the fastest growing segment of the pulmonary drug delivery systems market mainly due to the technical advances leading to portability of these devices and rising demand for home based care. The global pulmonary drug delivery systems market has also been segmented on the basis of their application in treating various diseases such as asthma, COPD and cystic fibrosis.

Among the four major geographies of the world, North America and Europe accounted for the first and second largest market shares in 2012 of the global pulmonary drug delivery systems market.The market in these regions is characterized by a range of factors such as patent expiry of many blockbuster inhaler brands, increasing prevalence of asthma and COPD, focus on reducing treatment costs, growing environmental concerns and aging population.Asia-Pacific held the third largest share of the global pulmonary drug delivery systems market in 2012. The region being home to more than half of the world’s population represents a large pool of patients suffering from respiratory diseases such as asthma and COPD, and thus, represents a high growth potential market for pulmonary drug delivery systems, estimated to grow at a CAGR of 6.6% during the forecast period.Emerging economies of India and China are expected to favor the positive growth of pulmonary drug delivery systems market in the region by contributing to the rise in healthcare expenditure.

The global market for pulmonary drug delivery systems is dominated by companies such as GlaxoSmithKline, plc, Boehringer Ingelheim, AstraZeneca, Merck & Co., Philips Respironics and Omron Healthcare. These players collectively accounted for more than 75% of the global pulmonary drug delivery systems market revenue in 2012.Some other players operating in this market include Novartis AG, CareFusion Corporation, 3M Health Care, PARI Respiratory Equipment, Inc., Sunovion Pharmaceuticals Inc., Allied Healthcare Products, Inc., and GF Health Products Inc.

Browse full PDF with TOC: Pulmonary Drug Delivery Systems Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The global pulmonary drug delivery systems market is segmented as follows:

Pulmonary Drug Delivery Systems Market, by Product Type

  • Metered Dose Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers

Pulmonary Drug Delivery Systems Market, by Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis

Pulmonary Drug Delivery Systems Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Distribution Automation Market is expected to reach USD 17,677.2 Million Globally in 2019: Transparency Market Research

EnergyAccording to a new market report published by Transparency Market Research “Distribution Automation (Monitoring and control devices, Power quality and efficiency devices, Switching and power reliability devices) Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 – 2019” the global distribution automation equipment market was worth USD 9,986.3 million in 2012 and is expected to reach USD 17,677.2 million by 2019, growing at a CAGR of 8.5% from 2013 to 2019. Europe was the largest market for distribution automation in 2012. The growth in this region would be driven increased investment in distribution automation equipment by richest European countries like UK, France, Italy and Germany. Further, according to Greentechgrid’s survey Europe invested USD 6.84 billion in smart meters starting from 2001 to 2012.

Browse Global Distribution Automation Market Report with Full TOC: http://www.transparencymarketresearch.com/distribution-automation-market.html

The distribution automation market is driven by various factors such as reduced outage durations, increased reliability and efficiency of distribution system and cost and maintenance reduction with improved power quality. However, lack of standardization in communication infrastructure and technology and modernization of existing switchgears are some of the factors inhibiting the growth of this market.

download-pdf

Among all types, in 2012, monitoring and control device was the largest segment and accounted for 36.1% of the global market. However, power quality and efficiency devices segment is expected to grow at a faster rate during forecast period.

In terms of end use segment, in 2012, industrial segment accounted for 51.3% of the total revenue of distribution automation market and is expected to remain dominating throughout the forecast period. Islanding operation, power quality improvement, load shedding, self-healing functionality and energy efficiency boost the demand for advanced distribution automation industrial segment. However, residential segment is expected to grow at the highest rate with a CAGR of 12.0% owing to need for improved reliability by reducing duration and number of outages as well as the quality of service.

Geographically Europe was the largest distribution automation market and accounted for 32.2% in 2012 owing to rise in number of smart grid projects and increased investment in distribution automation components, such as smart meters. Saved maintenance and operating cost is one of the major reasons for increasing demand of distribution automation in Europe.

Browse full PDF with TOC: Distribution Automation Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 – 2019

The global market for distribution automation is dominated by few players namely ABB Ltd., Siemens AG, Schneider Electric and GE Corporation. In 2012, ABB Ltd. and Siemens AG were the market leaders with 24%and 22% market share respectively. Other players in the market include GE, Schneider Electric, and Alstom Grid.

Distribution automation market, by type

  • Monitoring and control devices
  • Power quality and efficiency devices
  • Switching and power reliability devices

Distribution automation market, by end user

  • Industrial segment
  • Commercial segment
  • Residential segment

In addition the report provides cross sectional analysis of the market with respect to the following geographical segments:

  • North America
  • Europe
  • Asia-Pacific
  • RoW (Rest of the World)

Defibrillators Market is Expected to Reach USD 14.2 Billion Globally in 2019 Transparency Market Research

tmrlogoAccording to a new market report published by Transparency Market Research “Defibrillators Market (Advanced Life Support, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” the global defibrillators market was valued at USD 9.3 billion in 2012 and is expected to grow at a CAGR of 6.2% from 2013 to 2019, to reach an estimated value of USD 14.2billion in 2019.

Browse Global Defibrillators Market Report with Full TOC: http://www.transparencymarketresearch.com/defibrillators-market.html

Defibrillator devices are used to treat life-threatening cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia. These devices provide an electrical shock, having energy 40 – 400 Joule, to the heart muscles which terminates the arrhythmia and restores the normal sinus rhythm in the heart. Since the defibrillator devices are very useful in preventing deaths due to sudden cardiac arrest (SCA), the large number of SCA incidences across the globe is the major driver for the growth of this market.

download-pdf

Growing incidences of cardiovascular diseases and disorders combined with aging of baby boomer population in the U.S. are contributing to the growth of the global defibrillators market.Furthermore, the market is more driven by demand from emerging countries from Asia-Pacific and the Middle-East. Increasing trend towards installations of AEDs at workplaces by businesses is expected to serve as a good opportunity for the growth of global defibrillators market.

The global defibrillators market has been segmented on the basis of product types, end-users and geographic regions. On the basis of defibrillator types, the market is divided into advanced life support (ALS) defibrillators, automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs) and wearable defibrillators. In 2012, implantable defibrillator devices accounted for the largest share by revenue of the global defibrillators followed by ALS defibrillators.The global rise in the healthcare infrastructure which include state-of-the-art hospitals and ambulances equipped with advanced medical devices is seen as a driver for ALS defibrillator segment.

Browse full PDF with TOC: Defibrillators Market is Expected to Reach USD 14.2 Billion Globally in 2019 Transparency Market Research

The report also provides market estimations for the end-users of defibrillator devices during the forecast period of 2013 to 2019. The market has been categorized on the basis of end-users into five major segments, namely, hospitals, home, public access, emergency medical services and business workplace. In 2012, the hospitals as an end-user category shared more than 90%of the global defibrillator market.Other segments which are expected to grow rapidly during the forecast period are public access and business workplace. The government initiatives for creating awareness about the usefulness of AEDs in SCA will be the crucial factor for the growth of this market. Although the FDA initiatives to tighten the AED approval process, through pre-market approval (PMA), are likely to impact the market negatively, the grace period implementing changes is considerable enough for manufacturers in the defibrillators market.

Geographically, North America is the largest market for defibrillator devices and is expected to retain its top position throughout the forecast period. The rising awareness about the SCA and defibrillators in the USA and Canada is contributing to overall growth of defibrillators market in the region. In addition, legislations requiring installation of AEDs for public access and ‘Samaritan Laws’ providing immunity to first responders are driving factors for the market.Europe was the second largest market for defibrillator devices in 2012. During the forecast period, 2013 to 2019, Asia-Pacific and Middle-East are expected to grow at a faster pace than North America and Europe owing to the large patient base, increasing incidences of cardiovascular diseases and rising per capita expenditure on healthcare. The strengthening of economies in the Asia-Pacific and the subsequent rise in the healthcare infrastructure are propelling the market for defibrillators in this region.

The global defibrillators market is dominated by few major players such as Boston Medical Corporation, Medtronic, Inc. Philips Healthcare, St. Jude Medical, Inc. and Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation).

The global defibrillators market is segmented as follows:

Global Defibrillators Market, by Product Category

  • Advanced Life Support (ALS) Defibrillators
  • Automated External Defibrillators (AEDs)
  • Implantable Cardioverter Defibrillators (ICDs)
  • Wearable Defibrillators

Global Defibrillators Market, by End-Users

  • Hospitals
  • Home
  • Public Access
  • Emergency Medical Services
  • Business Workplace

Global Defibrillators Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Middle-East
  • Latin America
  • Africa